Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Grossman

Showing results (361-370 of 712) with videos related to

Pageof 72
Sort By:
Neuro-Oncology Practice|August 9, 2020
RAF and MEK inhibitor therapy in adult patients with brain tumors: a case-based overview and practical management of adverse eventsKarisa C Schreck, Mallika P Patel, Jan Wemmer, et al.
Scientific Reports|July 26, 2024
A safety evaluation of intermittent high-dose inhaled nitric oxide in viral pneumonia due to COVID-19: a randomised clinical studyTalya Wolak, D Dicker, Y Shifer, et al.
Journal of the American College of Emergency Physicians Open|August 6, 2024
Does initiating care in alternate care sites decrease time to disposition in the emergency department?Alyssa Mangino, Lakshman Balaji, Bryan Stenson, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1985
Treatment of lymphocele in renal allograft recipientsB M Greenberg, L J Perloff, R A Grossman, et al.
Acta Paediatrica Scandinavica. Supplement|January 1, 1987
Growth hormone releasing hormone in the assessment and long-term treatment of growth hormone deficiencyR J Ross, A Grossman, M A Preece, et al.
Cancer|April 10, 2004
ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomasMichael B Streiff, Jodi Segal, Stuart A Grossman, et al.
The Journal of Endocrinology|October 1, 1991
Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjectsE Ur, M Faria, S Tsagarakis, et al.
The Journal of Endocrinology|January 1, 1994
Lipopolysaccharide modulation of eicosanoid and corticotrophin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence for the involvement of prostaglandin E2 but not prostaglandin F2 alpha and lack of effect of nerve growth factorG Pozzoli, A Costa, M Grimaldi, et al.
Annals of Surgery|January 1, 1976
Acute colitis in the renal allograft recipientL J Perloff, H Chon, E J Petrella, et al.
The American Journal of Medicine|November 1, 1982
Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculographyS A Grossman, D L Trump, D C Chen, et al.
Pageof 72

Showing results (361-370 of 712) with videos related to

Sort By:
Pageof 72
Neuro-Oncology Practice|August 9, 2020
RAF and MEK inhibitor therapy in adult patients with brain tumors: a case-based overview and practical management of adverse eventsKarisa C Schreck, Mallika P Patel, Jan Wemmer, et al.
Scientific Reports|July 26, 2024
A safety evaluation of intermittent high-dose inhaled nitric oxide in viral pneumonia due to COVID-19: a randomised clinical studyTalya Wolak, D Dicker, Y Shifer, et al.
Journal of the American College of Emergency Physicians Open|August 6, 2024
Does initiating care in alternate care sites decrease time to disposition in the emergency department?Alyssa Mangino, Lakshman Balaji, Bryan Stenson, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1985
Treatment of lymphocele in renal allograft recipientsB M Greenberg, L J Perloff, R A Grossman, et al.
Acta Paediatrica Scandinavica. Supplement|January 1, 1987
Growth hormone releasing hormone in the assessment and long-term treatment of growth hormone deficiencyR J Ross, A Grossman, M A Preece, et al.
Cancer|April 10, 2004
ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomasMichael B Streiff, Jodi Segal, Stuart A Grossman, et al.
The Journal of Endocrinology|October 1, 1991
Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjectsE Ur, M Faria, S Tsagarakis, et al.
The Journal of Endocrinology|January 1, 1994
Lipopolysaccharide modulation of eicosanoid and corticotrophin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence for the involvement of prostaglandin E2 but not prostaglandin F2 alpha and lack of effect of nerve growth factorG Pozzoli, A Costa, M Grimaldi, et al.
Annals of Surgery|January 1, 1976
Acute colitis in the renal allograft recipientL J Perloff, H Chon, E J Petrella, et al.
The American Journal of Medicine|November 1, 1982
Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculographyS A Grossman, D L Trump, D C Chen, et al.
Pageof 72